Arlington Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2,971
Closed -$45.8K – 569
2022
Q4
$45.8K Buy
+2,971
New +$46K 0.01% 225

Other funds holding BMEZ

Arlington Partners's BMEZ Position: Q1 2023 in Review

Arlington Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2023, closing a stake of 2,971 shares — an estimated $45.8K sold.

Arlington Partners first reported a position in BMEZ in Q4 2022 and held it in 1 quarter. The position peaked at $45.8K in Q4 2022. 85 funds tracked by Wall St. Rank hold BMEZ as of Q1 2023.

  • Arlington Partners reported no remaining BlackRock Health Sciences Trust II position as of Q1 2023 after selling out during the quarter.
  • Arlington Partners sold 2,971 BlackRock Health Sciences Trust II shares in Q1 2023, an estimated $45.8K.
  • Arlington Partners first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and held it in 1 quarter.
  • Arlington Partners's BlackRock Health Sciences Trust II position peaked at $45.8K in Q4 2022.
  • 85 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2023.

Based on Arlington Partners's 13F filing for Q1 2023, filed 26 Apr 2023.